SynthesisBMC cardiovascular disorders2025
Artificial intelligence in cardiovascular diagnostics: a systematic review and descriptive analysis of clinical applications and diagnostic performance.
Synthesis in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Rethinking biomarkers in psychiatry: from etiological uncertainty to actionable prediction.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026Article
- Artificial intelligence-enabled electrocardiography to triage echocardiography for structural heart disease diagnosis in a low-resource setting.American journal of preventive cardiology · 2026Article
- Development and validation of an interpretable machine learning model for predicting the risk of coronary heart disease risk in diabetes mellitus patients: a dual-center retrospective study.BMC medical informatics and decision making · 2026Article
- Healthcare Providers' Perceptions and Multi-Level Determinants of Adoption of an AI-Powered Electrocardiography Interpretation Clinical Decision Support System in Ethiopia: A Formative Qualitative Study.International journal of environmental research and public health · 2026Article
- Navigating a new era in cardiovascular disease epidemiology: big data, artificial intelligence and the imperative of disability inclusion.Frontiers in epidemiology · 2026Review
- Ultrasound in cardiovascular care: a perspective on preventive, diagnostic, and monitoring applications.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionArtificial intelligence (AI) is rapidly transforming cardiovascular diagnostics by enhancing early disease detection, risk stratification, and clinical decision-making. Recent studies have shown the effectiveness of AI in analyzing electrocardiograms (ECGs) and cardiac imaging, predicting adverse cardiovascular outcomes, and enabling personalized care. AI models have also demonstrated potential in community-based and population-specific applications, signaling a shift toward data-driven, precision cardiovascular medicine. STUDY
objectiveTo systematically evaluate the clinical applications and diagnostic performance of AI in the detection and risk assessment of cardiovascular diseases.
methodsA systematic search was conducted in PubMed, Google Scholar, and ScienceDirect for English-language articles published between January 2020 and June 2025. Eligible studies included randomized controlled trials and observational designs with free full-text availability. QUADAS-2 tool for diagnostic accuracy studies and the PROBAST for prognostic or risk-prediction models, were used for quality assessment. Of 30 eligible articles, 14 high-quality studies were included.
resultsAcross the included studies, AI-based diagnostic tools demonstrated consistently high performance for cardiovascular disease detection. Reported area under the curve (AUC) values ranged from 0.804 to 0.991, with most ≥ 0.88, indicating robust discriminative accuracy across diverse modalities including ECG analysis, cardiac imaging, and predictive risk modeling. Although formal pooling was not conducted due to methodological heterogeneity, the descriptive synthesis highlighted strong and consistent performance in applications such as heart failure, coronary artery disease, and arrhythmia detection. Variability in study design and reporting limited direct comparison, but overall trends support the potential of AI systems to enhance diagnostic precision across cardiovascular contexts.
conclusionAI-driven diagnostic tools demonstrate consistently high accuracy across cardiovascular applications, supporting their potential to complement clinical decision-making. However, variability in study design and limited external validation highlight the need for standardized evaluation and transparent reporting before widespread clinical integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.